-
China’s Sinovac Biotech gets funding for Covid-19 vaccine development
pharmaceutical-technology
May 26, 2020
Chinese biopharmaceutical products company Sinovac Biotech has received $15m in funding to advance the development of its Covid-19 vaccine candidate, CoronaVac.
-
Takara Bio, AGC Biologics Enter Plasmid DNA Mfg. Pact
contractpharma
May 26, 2020
AGC to manufacture plasmid DNA intermediate for COVID-19 vaccine candidate.
-
Kindred, Vaxart Enter COVID-19 Vaccine Manufacturing Pact
contractpharma
May 26, 2020
Kindred Biosciences has entered into an agreement with Vaxart for the manufacture of Vaxart's oral vaccine candidate for COVID-19.
-
AstraZeneca Gets $1B from U.S. to Deliver COVID-19 Vax by Fall
contractpharma
May 26, 2020
Aims to make potential COVID-19 vaccine AZD1222 widely accessible with first deliveries in September 2020.
-
Moderna’s Covid-19 vaccine shows significant effect in early human trial
pharmaceutical-business-review
May 21, 2020
Moderna announced that its mRNA-1273 vaccine candidate against novel coronavirus (SARS-CoV-2) has demonstrated a significant effect in an early human trial.
-
Govt nod for manufacture of COVID-19 vaccine before clinical trials end will expedite access: Indust
expresspharma
May 21, 2020
Though certain rules have been deferred by the Government in the public interest to meet the emergent situation that has arisen out of COVID-19, the permission is subject to a few conditions.
-
Early data on Moderna’s COVID-19 vaccine insufficient: Stat News
expresspharma
May 21, 2020
Moderna said the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers.
-
Bharat Biotech, Thomas Jefferson University collaborate on COVID-19 vaccine candidate
expresspharma
May 21, 2020
The vector used in this new COVID-19 vaccine under accelerated development program is a deactivated rabies vaccine that is known to produce a strong immune response, and is approved for the whole population including children and pregnant women.
-
J&J signs Covid-19 vaccine manufacturing contract with Vibalogics
pharmaceutical-technology
May 20, 2020
Johnson & Johnson (J&J) has signed a deal with contract development and manufacturing organisation (CDMO) Vibalogics for the manufacture of clinical trial material for a Covid-19 vaccine candidate being developed by J&J unit Janssen Pharmaceutical.
-
Most UK adults believe COVID-19 vaccines and treatments should be distributed globally
europeanpharmaceuticalreview
May 19, 2020
A survey has revealed that the majority of adults in the UK believe governments need to work together to develop COVID-19 vaccines and treatments, which if effective, should be used worldwide.